Navigation Links
Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo-Regeneration
Date:7/1/2009

tent cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes and adipocytes. Dr. Parhami's discovery of specific pathways and small molecules that can induce differentiation to mature, bone-forming osteoblasts offers a new mechanism of intervention, which may be applied to treat a number of bone injuries and conditions, including non-union fracture, spinal fusion or osteoporosis. By collaborating with the foremost researchers and clinicians in the field of adult stem cell biology, Fate Therapeutics is continuing to expand its leadership position in the discovery and development of SCMs for regenerative medicine.

"Having an industry partner is essential to a successful translational drug discovery project, and we are excited about our collaboration with Fate Therapeutics to realize the full potential of our discoveries," said Dr. Parhami. "Our work has uncovered novel strategies and mechanisms for lineage-specific differentiation to an osteoblast phenotype. The ability to activate specific populations of stem cells in the body to promote bone regeneration may have many orthopedic clinical applications."

Dr. Parhami continued, "For example, with traumatic bone injuries, such as non-union fractures where the break in the bone cannot be healed without medical intervention, patients must undergo complicated surgeries and long recovery times. In the case of degenerative bone diseases, such as osteoporosis, current therapies focus on blocking bone degeneration rather than inducing formation. Being able to promote bone growth with novel osteogenic small molecules represents the next-generation of therapeutic agents for orthopedic medicine."

About Fate Therapeutics, Inc.

Fate Therapeutics is interrogating adult stem cell biology and applying induced pluripotent stem cell (iPSC) technology to develop Stem Cell Modulators (SCMs), small molecule or biologi
'/>"/>

SOURCE Fate Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Hyperion Therapeutics Raises $60 Million Series C
2. Cornerstone Therapeutics Joins the Russell 3000(R) Index
3. Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015, According to a New Report by Global Industry Analysts
4. Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market
5. Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
6. Prospect Therapeutics Inc.s GCS-100 Has Focused on Developing Treatment for Three Blood-Borne Cancers
7. Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
8. Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations
9. Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit
10. Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System
11. Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... San Antonio, TX (PRWEB) July 22, 2014 ... website. Designed with existing patients and new visitors in mind, ... a clean, modern and visual layout that makes navigation very ... to make the experience of going to the dentist affordable, ... , One helpful new feature is an appointment scheduling ...
(Date:7/22/2014)... Alexandria, Va. (PRWEB) July 22, 2014 ... Sept. 10, at the Ronald Reagan Building and ... “Transitioning Forward: Warriors, Military Families and Civilian Communities,” ... p.m., (registration opens at 7:30 a.m.) and cohosted ... and the National Defense Industrial Association (NDIA). USAA ...
(Date:7/22/2014)... 2014 Aaron Marshall, Corporate Counsel at Northrop ... and Speech Agency for the 2014-2015 fiscal year. He ... appointment, Marshall states, "“Serving on the HASA board has given ... and helps me remember how much others need help." , ... Aaron also has a B.S. in Finance from the University ...
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... treatments that break up blood clots deep in the veins ... risk. However, one results in a greater risk of bleeding ... of the other treatment, a new study finds. The ... thrombosis (DVT) -- is blood-thinning medications and compression stockings. The ...
(Date:7/22/2014)... 2014) The American Society of Hematology (ASH) ... of California Los Angeles with the 2014 E. ... homeostasis, including the discovery of the iron-regulatory hormone hepcidin ... award, named after the Nobel Prize Laureate and past ... achievements in hematology that have represented a paradigm shift ...
Breaking Medicine News(10 mins):Health News:Dr. Dental Reveals Exciting New Website 2Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 2Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 3Health News:New Board President for Baltimore-based Nonprofit 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 3Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3
... ... Center of Excellence – Their Call Center. , ... (PRWEB) February 2, 2010 -- Sacred Heart Health Systems ... specializing in women,s health, cardiac care, orthopedics, cancer care, and the care of children. ...
... ... to find the balance between investing in the necessary internal resources to implement online ... a dozen online tactics, and identifies where companies are using each tactic in the ... ...
... , EMERYVILLE, Calif. , ... Jamba Juice Company and The California Association for Health, Physical ... today for the "Most People Jumping/Skipping Rope at the Same ... off American Heart Month this morning at 9am , ...
... , WASHINGTON , Feb. 1 ... "Use of Herbal Products and Potential Interactions in Patients with ... of Cardiology, the Council for Responsible Nutrition (CRN), the leading ... statement: , Statement by Douglas MacKay, N.D., vice ...
... , ATLANTA , Feb. 1 Givers ... Renewal Fund at The National Christian Foundation (NCF) at ... to the NCF Haiti Renewal Fund will be matched dollar-for-dollar ... provide long-term support for rebuilding and renewing the country. For ...
... SANTA ANA, Calif. , Feb. 1 Grubb & ... and accepted subscriptions aggregating 2,000,000 shares of its common stock, or ... by the state of Ohio . Ohio residents ... Ellis Healthcare REIT II , Grubb & Ellis Healthcare REIT ...
Cached Medicine News:Health News:Sacred Heart Health Systems Utilizes Call Recording to Enhance Quality Process in Call Center 2Health News:Sacred Heart Health Systems Utilizes Call Recording to Enhance Quality Process in Call Center 3Health News:ckwrites.com Releases Report On Creating Online Marketing Tactics 2Health News:Update: Jamba Juice and CAHPERD Break Guinness World Record* for the 'Most People Jumping/Skipping Rope at the Same Time' 2Health News:Update: Jamba Juice and CAHPERD Break Guinness World Record* for the 'Most People Jumping/Skipping Rope at the Same Time' 3Health News:Update: Jamba Juice and CAHPERD Break Guinness World Record* for the 'Most People Jumping/Skipping Rope at the Same Time' 4Health News:Update: Jamba Juice and CAHPERD Break Guinness World Record* for the 'Most People Jumping/Skipping Rope at the Same Time' 5Health News:CRN Questions Accuracy of Herbal Products Article 2Health News:CRN Questions Accuracy of Herbal Products Article 3Health News:CRN Questions Accuracy of Herbal Products Article 4Health News:The National Christian Foundation Offers to Match Gifts to Haiti 2Health News:Grubb & Ellis Healthcare REIT II Meets Ohio's Minimum Offering 2
(Date:7/22/2014)... 22, 2014 Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) ... financial results after the market closes on Tuesday, August ... will be held on Tuesday, August 5, 2014, at ... To participate in the call, please dial 877-303-1298 ... rebroadcast of the teleconference will be available for one ...
(Date:7/22/2014)... July 22, 2014 Legislation backed by ... to Local Pharmacies Act of 2014") championing so-called ... would undermine the availability of lower cost preferred ... billion over the next 10 years, according to ... the Pharmaceutical Care Management Association (PCMA). ...
(Date:7/22/2014)... Pa. , July 22, 2014  Eyeon Therapeutics ... dry eye treatment based on a charged hydrophilic polymer ... The product has been shown to be safe and ... Mitchnick , MD, CEO states, "This first set of ... a long way to moving this technology into the ...
Breaking Medicine Technology:Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology 2
... Mass., Dec. 15, 2011  For parents, knowing how to take ... like sweat or drafts affect the accuracy of results can ... Vicks ® Behind ... out of measuring for fever, restoring confidence to parents and ...
... 2011   Enlight Biosciences LLC announced today ... and Novo Nordisk.  As partners in Enlight, AstraZeneca and ... and invest in the development of potentially transformational ... was created by PureTech Ventures in partnership with ...
Cached Medicine Technology:Behind The Ear -- A New Site To Measure for Fever 2Behind The Ear -- A New Site To Measure for Fever 3Enlight Biosciences Forms New Partnerships with AstraZeneca and Novo Nordisk 2Enlight Biosciences Forms New Partnerships with AstraZeneca and Novo Nordisk 3
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
... 20-year history, the VOYAGER RX Dilatation Catheter ... outcomes. It combines a new low profile, ... shaft,more flexible markers, and short taper balloon ... tortuous anatomy with even greater confidence, opening ...
... developed over Guidants 20-year history, the VOYAGER ... for successful treatment outcomes. It combines a ... a lower profile shaft,more flexible markers, and ... cross tight and tortuous anatomy with even ...
Medicine Products: